Comparison between Mono Pharmacare IPO and Shoora Designs IPO.
Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shoora Designs IPO is a SME Fixed Price proposed to list at BSE SME.
| Mono Pharmacare IPO | Shoora Designs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Unistone Capital Pvt.Ltd. | Swaraj shares & securities Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Rikhav Securities Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Shoora Designs IPO is up to ₹1.90 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Shoora Designs IPO is ₹48.00 per share.
| Mono Pharmacare IPO | Shoora Designs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹26.00 per share | |
| Issue Price (Upper) | ₹28.00 per share | |
| Issue Price (Final) | ₹28.00 per share | ₹48.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 3000 shares |
| Fresh Issue Size | 50,24,000 shares | 3,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.07 Cr | up to ₹1.90 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 50,24,000 shares | 3,96,000 shares |
| Issue Size Total (Amount) | up to ₹14.07 Cr | up to ₹1.90 Cr |
Mono Pharmacare IPO opens on Aug 28, 2023, while Shoora Designs IPO opens on Aug 17, 2023. The closing date of Mono Pharmacare IPO and Shoora Designs IPO is Aug 30, 2023, and Aug 21, 2023, respectively.
| Mono Pharmacare IPO | Shoora Designs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 28, 2023 | Aug 17, 2023 |
| Issue Close | Aug 30, 2023 | Aug 21, 2023 |
| Basis Of Allotment (Tentative) | Sep 04, 2023 | Aug 24, 2023 |
| Initiation of Refunds (Tentative) | Sep 05, 2023 | Aug 25, 2023 |
| Credit of Share (Tentative) | Sep 06, 2023 | Aug 28, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Aug 29, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mono Pharmacare IPO P/E ratio is , as compared to Shoora Designs IPO P/E ratio of 35.82.
| Mono Pharmacare IPO | Shoora Designs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.02 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 35.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.47 Cr. | ₹7.19 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.01 | 14.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.34 | 9.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.99 | ₹1.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 9.01 | 7.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Shoora Designs IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Shoora Designs IPO.
| Mono Pharmacare IPO | Shoora Designs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,76,000 shares | 27,000 shares |
| QIB | 5,00,000 shares | |
| NII | 22,60,000 shares | 1,98,000 shares |
| RII | 22,64,000 shares | 1,98,000 shares |
| Employee | ||
| Others | ||
| Total | 50,24,000 shares | 3,96,000 shares |
Mono Pharmacare IPO subscribed 13.42x in total, whereas Shoora Designs IPO subscribed 64.52x.
| Mono Pharmacare IPO | Shoora Designs IPO | |
|---|---|---|
| QIB (times) | 10.89x | |
| NII (times) | 8.00x | 34.68x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.40x | 93.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 13.42x | 64.52x |
